UB Paderborn / Katalog / Suche / in CDI

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study

Journal of child and adolescent psychopharmacology, 2023-03, Vol.33 (2), p.51

2023

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2021-11, Vol.31 (9), p.597

2021

Link zum Volltext

Verfügbarkeit prüfen

Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study

Frontiers in psychiatry, 2024-03, Vol.15, p.1310483-1310483

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia

The journal of clinical psychiatry, 2022-11, Vol.84 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

Behavioral and brain functions, 2010-06, Vol.6 (1), p.34-34

2010

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations

Neuropsychiatric disease and treatment, 2021-01, Vol.17, p.1589-1597

2021

Link zum Volltext

Verfügbarkeit prüfen

A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2012, Vol.51 (1), p.74-85.e2

2012

Link zum Volltext

Verfügbarkeit prüfen

5.7 COMPARATIVE BIOAVAILABILITY AND SAFETY OF A NOVEL TRIMODAL DEXMETHYLPHENIDATE TABLET IN ADHD PATIENTS

Journal of the American Academy of Child and Adolescent Psychiatry, 2020-10, Vol.59 (10), p.S150-S151

2020

Link zum Volltext

Verfügbarkeit prüfen

Response/Remission With Guanfacine Extended-Release and Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2014-10, Vol.53 (10), p.1092-1101

2014

Link zum Volltext

Verfügbarkeit prüfen

Dexmethylphenidate ExtendeD-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2008-02, Vol.47 (2), p.199-208

2008

Link zum Volltext

Verfügbarkeit prüfen

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder

Journal of autism and developmental disorders, 2016-04, Vol.46 (4), p.1153-1163

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design

Postgraduate medicine, 2018-07, Vol.130 (5), p.481-493

2018

Link zum Volltext

Verfügbarkeit prüfen

Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD

Pediatrics (Evanston), 2011-06, Vol.127 (6), p.e1406

2011

Link zum Volltext

Verfügbarkeit prüfen

Serdexmethylphenidate/dexmethylphenidate capsules for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): a plain language summary

Future neurology, 2024-03, Vol.19 (1)

2024

Link zum Volltext

Verfügbarkeit prüfen

1.38 Efficacy and Safety of SHP465 Mixed Amphetamine Salts in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized, Placebo-Controlled Study

Journal of the American Academy of Child and Adolescent Psychiatry, 2017-10, Vol.56 (10), p.S165-S165

2017

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings

Journal of child and adolescent psychopharmacology, 2020-02, Vol.30 (1), p.2

2020

Link zum Volltext

Verfügbarkeit prüfen

Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design

The journal of clinical psychiatry, 2012-07, Vol.73 (7), p.977

2012

Link zum Volltext

Verfügbarkeit prüfen

Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

The journal of clinical psychiatry, 2008-09, Vol.69 (9), p.1364

2008

Link zum Volltext

Verfügbarkeit prüfen

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

Child and adolescent psychiatry and mental health, 2009-06, Vol.3 (1), p.17-17, Article 17

2009

Link zum Volltext

Verfügbarkeit prüfen

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study

Journal of child and adolescent psychopharmacology, 2015-06, Vol.25 (5), p.402

2015

Link zum Volltext

Verfügbarkeit prüfen

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder

Journal of child and adolescent psychopharmacology, 2011-04, Vol.21 (2), p.121

2011

Link zum Volltext

Verfügbarkeit prüfen

A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia

Schizophrenia research, 2014-03, Vol.153 (1), p.160-168

2014

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blind Study of 30 Versus 20 mg Dexmethylphenidate Extended-Release in Children With Attention-Deficit/Hyperactivity Disorder: Late-Day Symptom Control

Journal of clinical psychopharmacology, 2012-10, Vol.32 (5), p.637-644

2012

Link zum Volltext

Verfügbarkeit prüfen

Duration of effect of oral long-acting stimulant medications for ADHD throughout the day

Current medical research and opinion, 2010-08, Vol.26 (8), p.1809-1825

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults

Current medical research and opinion, 2011-10, Vol.27 (S2), p.23-33

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study

A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder

Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study

Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations

A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder

5.7 COMPARATIVE BIOAVAILABILITY AND SAFETY OF A NOVEL TRIMODAL DEXMETHYLPHENIDATE TABLET IN ADHD PATIENTS

Response/Remission With Guanfacine Extended-Release and Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Dexmethylphenidate ExtendeD-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder

A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design

Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD

Serdexmethylphenidate/dexmethylphenidate capsules for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): a plain language summary

1.38 Efficacy and Safety of SHP465 Mixed Amphetamine Salts in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized, Placebo-Controlled Study

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings

Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design

Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder

A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia

A Randomized, Double-Blind Study of 30 Versus 20 mg Dexmethylphenidate Extended-Release in Children With Attention-Deficit/Hyperactivity Disorder: Late-Day Symptom Control

Duration of effect of oral long-acting stimulant medications for ADHD throughout the day

Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults

Suchergebnisse filtern